CTI BioPharma
CTI BioPharma

CTI BioPharma Information

Contact top employees from CTI BioPharma

Summary

CTI BioPharma is a public company that has been in the industry for 35 years. The company currently specializes in the Biotechnology, Biotechnology, Pharmaceuticals areas. The position of the President & CEO is occupied by Adam R. Craig. Its headquarters is located at Seattle, Washington, USA. The number of employees ranges from 1 to 25. The annual revenue of CTI BioPharma varies between 100K and 5.0M. Total funding of the company - $45.9M. To connect with CTI BioPharma employee register on SignalHire.

Organization Website

sobi.com

Phone Number

206-282-7100

Industries

Headquarters Location

3101 Western Ave., #600, Seattle, WA, 98121 US

Employees Size

100-200 employees

Specialties

Biotechnology

SIC Code

2836

DMA Code

Seattle Metropolitan Area

Founded

1992

Estimated Annual Revenue

$100K - 5.0M

Operating Status

Independent Company

Competitors

Founded
Type
Employees
Revenue
Funding
2004Public
Company
100 - 250 5.1M $91.2M
2015Public
Company
100 - 250 1.2M $266.9M
2000Public
Company
100 - 250 38.4M $361.3M
2009Privately
Held
25 - 100 5.6M $197.7M

Estimated Website Traffic

The chart shows a decline in traffic to the sobi.com website. In December, traffic decreased to 104811, compared to 112199 in the previous month. The highest traffic in 2025 was recorded in November, reaching 112199 visits.

Employees Turnover 4 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at CTI BioPharma shows a diverse range of experience levels:
4% for 1–2 years10% for 3–4 years6% for 5–7 years5% for 8–10 years76% have over 11 years of service at CTI BioPharma
Ex-employees positions
In Company
In New Company
Contact top employees from CTI BioPharma
Steve Cope
Sr. Vice President, Human Resource Development
View
John Volpone
Executive Vice President Corporate Development
View
Tom Blackwell
Vice President, Information Technology
View
Jolynn Wynn
Facilities Operations Coordinator
View
Natasha Bianco
Human Resources and Operations Intern
View
Christy Machida
Drug Safety Physician
View
Felicia Wibowo
Software Consultant
View
Ai Justice
Staff Accountant
View
Vivian Doolittle
Senior Executive Assistant
View
NEIL CORBIN
Director, Global Medical Affairs Operations
View
Kim Lohr BSN
Key Account Manager
View
Margaret Li
Biopharmaceutical R&D Consultant
View
Steve Cope
Human Resource Consultant
View
Emily Ma
Biopharmaceutical R&D Manager
View
Anna Mu
Biopharmaceutical Consultant
View
Emily Cheng
R&D Manager
View
Cindy Li
Biopharmaceutical R&D Manager
View
Ruyue Mu
Biopharmaceutical R&D Manager
View
Stephanie Dellinger
Key Account Manager
View
Christi Murphy
Key Account Manager
View
Joe Mansfield
VP US Sales and Sales Operations
View
Monica Desimone
Director Financial Planning Analysis
View
Onna Turner
Receptionist
View
Ann Herbig
Director, IT - Business & GxP Systems
View
Esther Stapleton
Senior Accountant
View
Amber Jackson
Senior Administrative/Project Assistant, Biometrics & HEOR
View
Brent Satterlee
Senior Stock Plan Manager
View

FAQ

CTI BioPharma operates in the Biotech industries. More details can be found on the official website: sobi.com.
The headquarters of CTI BioPharma are located in Seattle, United States.
The current CEO of CTI BioPharma is Adam R. Craig
You can contact CTI BioPharma by phone at 206-282-7100.
CTI BioPharma currently employs 100-200 people.
CTI BioPharma's revenue is approximately 3.3M.
Well-known competitors of CTI BioPharma include PHAXIAM Therapeutics, AVROBIO, Immatics and Aura Biosciences.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP